Shukra Pharmaceuticals Limited works in the pharmaceutical industry. They started operations with a fully integrated factory in Rakanpor, Gandhinagar, Gujarat. Even since its inception, the company has climbed to enormous heights in terms of operations and has greatly grown.
In Ahmedabad, they now have an internationally approved laboratory where they create each product to the greatest quality standards.
Shukra Pharmaceuticals undertake operations including-
- Contract Manufacturing
- Loan License
- Domestic and International Operations
Shukra Pharmaceuticals’ staff of research analysts, medical officers, and technical experts ensures the quality of each product and follows to tight rules in order to supply it.
Objects of the Issue:
The Company proposes to utilize the Net Proceeds to:
- To augment the existing and incremental working capital requirement of the company; and
- General Corporate Purposes
Shukra Pharmaceuticals Rights Issue 2023 Detail
Issue Open | Feb 15, 2023 – Feb 28, 2023 |
Security Name | Shukra Pharmaceuticals Limited |
Issue Size (Shares) | 9,394,050 |
Issue Size (Amount) | ₹18.79 Crores |
Issue Price | ₹20 per share |
Face Value | ₹10 per share |
Listing At | BSE |
Terms of Payment | Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined. |
Entitlement | 6 Equity Shares for every 1 Fully Paid Equity Share held |
Shukra Pharmaceuticals Rights Issue 2023 Issue Timetable
Shukra Pharmaceuticals Rights Issue 2023 Registrar
- Purva Sharegistry India Pvt Ltd
Phone: +91-022-23018261/ 23016761
Email: [email protected]
Website: http://www.purvashare.com
Company Contact Information
Shukra Pharmaceuticals Limited
Veer House, 3rd Floor, Judges Bungalow Road,
Opp. WIAA Motor Training School,
Bodakdev, Ahmedabad- 380054
Phone: +91 79 48901030
Email: [email protected]
Website: http://www.shukrapharmaceuticals.com
Shukra Pharmaceuticals Rights Issue 2023 Registrar
Purva Sharegistry India Pvt Ltd
Phone: +91-022-23018261/ 23016761
Email: [email protected]
Website: http://www.purvashare.com
Shukra Pharmaceuticals Rights Issue 2023 FAQs
Q1. When is Shukra Pharmaceuticals Rights Issue 2023 coming?
Ans. The Shukra Pharmaceuticals Rights Issue 2023 opens on Feb 15, 2023, and closes on Feb 28, 2023.
Q2. What is the schedule for Shukra Pharmaceuticals Rights Issue 2023?
Ans. Shukra Pharmaceuticals Rights Issue 2023 Schedule : Last Date for credit of Rights Entitlements Feb 13, 2023 Last Date for renunciation of Rights Entitlements Feb 23, 2023 Issue Opening Date Feb 15, 2023 Issue Closing Date Feb 28, 2023 Date of Allotment (on or about) Mar 8, 2023 Date of Credit (on or about) Mar 14, 2023 Date of Listing (on or about) Mar 15, 2023
Q3. What is the issue price for Shukra Pharmaceuticals Rights Issue 2023?
Ans. Shukra Pharmaceuticals Rights Issue 2023 price is set at ₹20 per share per equity share.
Q4. In what ratio is the Shukra Pharmaceuticals Rights Issue 2023 offered?
Ans. The eligible shareholders are being offered 6 Equity Shares for every 1 Fully Paid Equity Share held (Feb 2, 2023).
Q5. What is the record date for Shukra Pharmaceuticals Rights Issue 2023?
Ans. The record date for the Shukra Pharmaceuticals Rights Issue 2023 is Feb 2, 2023.
Q6. What is the issue size of Shukra Pharmaceuticals Rights Issue 2023?
Ans. The issue size of Shukra Pharmaceuticals Rights Issue 2023 is of 9,394,050 equity shares at ₹20 per share aggregating upto ₹18.79 Crores.
Q7. How to apply for Shukra Pharmaceuticals Rights Issue 2023?
Ans. You can apply for Shukra Pharmaceuticals Rights Issue 2023 in two ways:
- Net Banking (ASBA)
- Registrar’s Website (R-WAP Facility)
Steps to apply for Shukra Pharmaceuticals Rights Issue 2023 using Net Banking (ASBA)
- Log in to the net banking account of your bank.
- Go to the ‘IPO & Rights Issue’ section.
- Check if the Shukra Pharmaceuticals Rights Issue 2023 available on the list.
- Click the Apply button next to the Shukra Pharmaceuticals Rights Issue 2023.
- Fill and check your information.
- Submit the application.
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Shukra Pharmaceuticals Rights Issue 2023 using Registrar’s website (R-WAP)
- Visit registrar’s website
- Go to the ‘Rights Issue’ section
- Select Shukra Pharmaceuticals Rights Issue 2023 from the dropdown.
- Enter Demat Account Number.
- Fill the online application form.
- Validate and submit the application.